8
Oct
2024
Luohe Chief Pharmaceutical Co., Ltd.
Exhibitor at CPHI Milan 2024 stand 4D1, API
About Us
Categories
-
CN
-
2018On CPHI since
-
100 - 249Employees
Company types
Event information
CPHI Milan 2024
-
08 Oct 2024 - 10 Oct 2024
-
Fiera Milano, Italy
-
Visit us at stand 4D1, API
Products Featured at CPHI Milan 2024
-
Product RIFABUTIN
Rifabutin: Amorphous red-purple powder, an active ingredient used to treat tuberculosis, Helicobacter pylori and the mycobacterium avium complex.CAS:72559-06-9
Specification:EP/USP
Packing:15Kg/Drum
Documents:DML, WC, DMF, CEP, USDMF -
Product RIFAMPICIN
Rifmpicin: Red to brownish-red crystalline powder, an active ingredient used to treat tuberculosis. -
Product RIFAXIMIN
Rifaximin: Red-orange crystalline powder, an antibiotic used to treat traveler's diarrhea, irritable bowel syndrome and hepatic encephalopathy. -
Product RIFAMYCIN SODIUM
Rifamycin Sodium: Fine or granular red powder, an active ingredient used to treat tuberculosis, travelers' diarrhea. -
Product RIFAPENTINE
Rifapentine: Dark red to reddish-brown crystalline powder, an antibiotic used to treat tuberculosis.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance